SunRegen is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases.

Products, services, technology

SunRegen is focusing on innovative treatments for patients suffering from neurological, neuromuscular and ophthalmic diseases. Our first product candidates in development target ophthalmic disease. We further evaluate them for use in serious neurological / neuromuscular diseases

Cooperation possibilities

SunRegen is open to collaborate with academia and industrial partners.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2017
  • Number of employees in Switzerland
    1-9
Key business